Evaluation Only. Created with Aspose.PDF. Copyright 2002-2021 Aspose Pty Ltd.
3630
S. S. Hah et al. / Bioorg. Med. Chem. Lett. 15 (2005) 3627–3631
Most of the previous model studies on the oxidation of
8-oxodG were performed using protected 8-oxodG
derivatives, such as OG, to prevent oxidation of 50-OH
and to allow longer retention times and better resolution
by HPLC owing to higher hydrophobicity compared to
the unprotected 20-deoxynucleosides. Because of the
possibility of oxidation of 50-OH by IrIV complexes in
this study, the silver mirror experiment for detection
of aldehydes was used, in which the presence of the func-
We are now investigating enzymatic digestion of the
radiolabeled DNA to 20-deoxynucleosides to determine
to what extent the 8-oxodG is oxidized in vivo, either
in the nucleotide pool or in the newly synthesized
DNA. These data indirectly support the formation of
the triphosphate of 8-oxodG or its oxidation products
via the nucleotide salvage pathway which serves as a
substrate for DNA polymerase(s) to enable incorpora-
tion of the modified nucleoside derivative into DNA.
+
tional group reduces Ag(NH3)2 to metallic silver. No
aldehyde was detected in the purified products, dGh
and dSp. In contrast, the oxidation of 8-oxodG with
peroxynitrite, a potent oxidant that is probably formed
in vivo, led to the production of several aldehydes, likely
resulting from the oxidation of 50-OH of the deoxyri-
bose ring (data not shown). Clearly, exploitation of
the proper oxidant for 8-oxodG oxidation can lead to
selective oxidation of the purine ring instead of the
OH groups of the ribose ring. Any aldehyde product(s)
may be of little biological consequence since their 50-OH
group(s) would no longer be available for phosphoryla-
tion by kinases that participate in the nucleoside salvage
pathway.
It is tempting to speculate that dG can be first oxidized
to 8-oxodG via a variety of mechanisms, and can then
be oxidized to dGh and dSp via a one-electron oxidation
mechanism. Alternatively, these nucleoside derivatives
may be formed directly from dG. The nucleosides dGh
and dSp, and their corresponding mono-, di-, and tri-
phosphates, if formed in vivo, are likely to be available
in the nucleotide pool for subsequent promutagenic
incorporation into DNA. The proportion of the dSp
and dGh that is ultimately present in DNA may be gov-
erned by the chemistry of their formation in a substitu-
ent-dependent fashion.
To explore the in vivo oxidation of 8-oxodG, MCF-7
human breast cancer cells were grown in the presence
Acknowledgments
of ꢁ10 pmol of 14C-labeled 8-oxodG for 0, 1, 2, and 4
We acknowledge Kurt Hack for preparation of AMS
samples and John Vogel, Karen Dingley, and Kenneth
Turteltaub for helpful advice and interpretation of the
data. This work was performed at the Research Re-
source for Biomedical Accelerator Mass Spectrometry,
operated at University of California Lawrence Liver-
more National Laboratory under the auspices of the
U.S. DOE Contract W-7405-ENG-48 and partially sup-
ported by NIH/NCRR, Biomedical Technology Pro-
gram Grant P41 RR13461, NIH Grant CA55861, and
by the California Breast Cancer Research Program
Grant 9KB-0179.
14
days, respectively.
Isolated DNA was assayed for
the presence of the radiolabel using accelerator mass
spectrometry, a method for the quantitation of small
amounts of radiocarbon (zeptomol sensitivity) with high
precision.15 Figure 4 shows that radiolabeled nucleoside
incorporation into DNA reached a maximum of
ꢁ10,000 amol/100 lg of DNA after 2 days and then de-
creased ꢁ2-fold by day 4, presumably due to DNA re-
pair competing with radiolabeled 20-deoxynucleoside
incorporation. Clearly, this experiment demonstrated
that modified 20-deoxynucleoside(s) can be incorporated
into cellular DNA at biologically relevant levels. This
experiment, to our knowledge, represents the first report
of direct measurement of 8-oxodG incorporation into
DNA in vivo. The 14C-labeled 8-oxodG may have, in
part, been converted to additional products in vivo.
References and notes
1. (a) Burrows, C. J.; Muller, J. G. Chem. Rev. 1998, 98,
1109; (b) Burrows, C. J.; Muller, J. G.; Kornyushyna, O.;
Luo, W.; Duarte, V.; Leipold, M. D.; David, S. S. Environ.
Health Perspect. 2002, 110, 713; (c) Sugden, K. D.;
Martin, B. D. Environ. Health Perspect. 2002, 110, 725;
(d) Cadet, J.; Douki, T.; Gasparutto, D.; Ravanat, J. L.
Mutat. Res. 2003, 531, 5.
2. Steenken, S.; Jovanovic, S. V. J. Am. Chem. Soc. 1997,
119, 617.
3. (a) Duarte, V.; Muller, J. G.; Burrows, C. J. Nucleic Acids
Res. 1999, 27, 496; (b) Niles, J. C.; Burney, S.; Singh, S. P.;
Wishnok, J. S.; Tannenbaum, S. R. Proc. Natl. Acad. Sci.
USA 1999, 96, 11729; (c) Henderson, P. T.; Jones, D.;
Hampikian, G.; Kan, Y. Z.; Schuster, G. B. Proc. Natl.
Acad. Sci. USA 1999, 96, 8353; (d) Kasai, H.; Yamaizumi,
Z.; Berger, M.; Cadet, J. J. Am. Chem. Soc. 1992, 114,
9692; (e) Ravanat, J. L.; Cadet, J. Chem. Res. Toxicol.
1995, 8, 379; (f) Raoul, S.; Berger, M.; Buchko, G. W.;
Prakash, C.; Joshi, P. C.; Morin, B.; Weinfeld, M.; Cadet,
J. J. Chem. Soc., Perkin Trans. 2 1996, 371; (g) Gasp-
arutto, D.; Ravanat, J. L.; Gerot, O.; Cadet, J. J. Am.
Chem. Soc. 1998, 120, 10283; (h) Muller, J. G.; Duarte, V.;
Hickerson, R. P.; Burrows, C. J. Nucleic Acids Res. 1998,
Figure 4. Incorporation of 14C-labeled 8-oxodG into the DNA of
growing MCF-7 human breast cancer cells. The ratio of 14C to total
carbon contained in the purified genomic DNA was measured with
accelerator mass spectrometry. Experiments were performed in
triplicate.